Met interaction with Fis1 could also occur in other types of human cancer cells like HCC1806 breast cancer cells (Supplementary Fig. S2c) and HT29 colon cancer cells (Supplementary Fig. S2d), which was analogously enhanced by HGF but diminished by crizotinib. Here, FIS1 is linked to breast cancer.